Drug-loaded nanoparticles for cancer therapy: a high-throughput multicellular agent-based modeling study

Area of Science:

• Biomedical Engineering
• Computational Biology
• Nanotechnology

Background:

• Nanomaterial applications in medicine, particularly cancer therapy, necessitate understanding complex biological interactions.
• Existing models often lack focus on individual cell-nanoparticle (NP) dynamics crucial for cancer nanotherapy.
• A systems-level approach using mathematical modeling is vital for analyzing NP-cell-tissue interactions and patient response.

Purpose of the Study:

• To develop a multicellular agent-based model simulating nanoparticle (NP) interactions in cancer nanotherapy.
• To investigate the impact of NP pharmacokinetics and therapeutic strategies on tumor dynamics.
• To explore the role of NP 'inheritance' by daughter cells during cell division on therapeutic outcomes.

Main Methods:

• Developed a multicellular agent-based model for cancer nanotherapy.
• Simulated NP internalization, intracellular drug release, NP inheritance, and cell pharmacodynamics.
• Utilized a large-scale parallel computational framework to analyze parameters influencing tumor dynamics.

Main Results:

• NP inheritance at cell division can enhance treatment efficacy for cytotoxic chemotherapy.
• Optimized, smaller dosages of cytostatic chemotherapy can improve tumor growth inhibition.
• Slow delivery via 'heritable' NPs offers new avenues for sustained nanotherapy design.

Conclusions:

• Agent-based modeling provides a powerful tool for simulating and optimizing cancer nanotherapy.
• Nanoparticle inheritance during cell division is a key factor influencing treatment effectiveness.
• Strategic design of 'heritable' nanoparticles can lead to more sustained and effective cancer treatment.